Overcoming imatinib resistance conferred by the BIM deletion polymorphism in chronic myeloid leukemia with splice-switching antisense oligonucleotides | Oncotarget
Overcoming imatinib resistance conferred by the BIM deletion polymorphism in chronic myeloid leukemia with splice-switching antisense oligonucleotides | Oncotarget
Overcoming imatinib resistance conferred by the BIM deletion polymorphism in chronic myeloid leukemia with splice-switching antisense oligonucleotides | Oncotarget,The Cancer Antioxidant Regulation System in Therapeutic Resistance,Review of Nanoscale Approaches for Tailoring Electrode Materials for Advanced Energy Storage Systems | ACS Applied Nano Materials,A fixed phase tunable directional coupler based on coupling tuning | Scientific Reports,Redox-Regulated Iron Metabolism and Ferroptosis in Ovarian Cancer: Molecular Insights and Therapeutic Opportunities